Our vision is bold—to modify the tumor phenotype, allowing for new therapeutic opportunities that restore or extend the benefit of targeted therapies.
Our vision is practical—to develop effective regimens that have broad commercial potential by optimizing features important to patients, physicians, and payers.
Our vision is practical—to develop effective regimens that have broad commercial potential by optimizing features important to patients, physicians, and payers.